Simplex Trading
ABBV icon

Simplex Trading’s AbbVie ABBV Stock Holding History

Simplex Trading’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.1M Sell
120,000
-73,200
-38% -$16.2M 0.02% 358
2025
Q4 		$44.1M Buy
193,200
+6,600
+4% +$1.5M 0.02% 319
2025
Q3 		$43.2M Sell
186,600
-187,400
-50% -$38.2M 0.02% 387
2025
Q2 		$69.4M Sell
374,000
-193,900
-34% -$36M 0.04% 225
2025
Q1 		$119M Sell
567,900
-57,000
-9% -$11.1M 0.08% 121
2024
Q4 		$111M Buy
624,900
+87,200
+16% +$16M 0.06% 153
2024
Q3 		$106M Sell
537,700
-50,900
-9% -$9.5M 0.06% 149
2024
Q2 		$101M Buy
588,600
+32,700
+6% +$5.42M 0.06% 157
2024
Q1 		$101M Sell
555,900
-567,700
-51% -$97.8M 0.06% 173
2023
Q4 		$174M Buy
1,123,600
+216,700
+24% +$31.6M 0.11% 89
2023
Q3 		$135M Sell
906,900
-54,100
-6% -$7.94M 0.11% 94
2023
Q2 		$129M Buy
961,000
+231,900
+32% +$34M 0.11% 96
2023
Q1 		$116M Buy
729,100
+152,200
+26% +$23.3M 0.1% 136
2022
Q4 		$93.2M Buy
576,900
+134,300
+30% +$20.6M 0.1% 153
2022
Q3 		$59.4M Sell
442,600
-279,100
-39% -$40.1M 0.07% 206
2022
Q2 		$111M Sell
721,700
-118,700
-14% -$18.1M 0.12% 99
2022
Q1 		$136M Buy
840,400
+228,900
+37% +$33.3M 0.12% 109
2021
Q4 		$82.8M Buy
611,500
+44,700
+8% +$5.28M 0.08% 180
2021
Q3 		$64.8M Sell
566,800
-22,200
-4% -$2.54M 0.06% 211
2021
Q2 		$66.3M Buy
589,000
+584,193
+12,153% +$65.8M 0.06% 202
2021
Q1 		$52M Buy
4,807
+1,189
+33% +$127K 0.09% 131
2020
Q4 		$38.8M Sell
3,618
-593
-14% -$57K 0.05% 213
2020
Q3 		$36.9M Buy
4,211
+180
+4% +$16.9K 0.05% 207
2020
Q2 		$39.6M Sell
4,031
-2,472
-38% -$218K 0.06% 170
2020
Q1 		$49.5M Buy
6,503
+1,247
+24% +$106K 0.09% 118
2019
Q4 		$46.5M Sell
5,256
-1,328
-20% -$110K 0.1% 117
2019
Q3 		$49.9M Buy
6,584
+471
+8% +$32.3K 0.14% 93
2019
Q2 		$44.5M Buy
6,113
+1,765
+41% +$139K 0.12% 97
2019
Q1 		$35M Buy
4,348
+1,034
+31% +$84.6K 0.1% 136
2018
Q4 		$30.6M Sell
3,314
-1,048
-24% -$92.2K 0.09% 137
2018
Q3 		$41.3M Sell
4,362
-313
-7% -$29.7K 0.13% 106
2018
Q2 		$43.3M Sell
4,675
-160
-3% -$15.6K 0.17% 89
2018
Q1 		$668K Buy
4,835
+2,247
+87% +$247K 0.03% 565
2017
Q4 		$1.27M Sell
2,588
-432
-14% -$40.7K 0.05% 309
2017
Q3 		$1.92M Buy
3,020
+960
+47% +$73.1K 0.08% 200
2017
Q2 		$659K Sell
2,060
-2,539
-55% -$171K 0.03% 520
2017
Q1 		$548K Buy
4,599
+81
+2% +$5.09K 0.02% 629
2016
Q4 		$550K Buy
4,518
+890
+25% +$54.3K 0.03% 501
2016
Q3 		$239K Buy
3,628
+1,284
+55% +$83.1K 0.02% 905
2016
Q2 		$544K Buy
2,344
+648
+38% +$39.5K 0.04% 485
2016
Q1 		$322K Buy
1,696
+497
+41% +$27.7K 0.03% 622
2015
Q4 		$210K Buy
1,199
+463
+63% +$26.7K 0.02% 844
2015
Q3 		$134K Sell
736
-1,177
-62% -$76.6K 0.01% 1181
2015
Q2 		$2.56M Sell
1,913
-227
-11% -$14.8K 0.21% 79
2015
Q1 		$354K Buy
2,140
+875
+69% +$52.9K 0.04% 445
2014
Q4 		$1.31M Buy
+1,265
New +$79.8K 0.16% 111

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Simplex Trading's ABBV Position: Q1 2026 in Review

Simplex Trading sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 8,076 shares — an estimated $1.79M sold.

Simplex Trading first reported a position in ABBV in Q1 2015 and held it in 25 quarters. The position peaked at $24.6M in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Simplex Trading reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 8,076 AbbVie shares in Q1 2026, an estimated $1.79M.
  • Simplex Trading first reported a position in AbbVie in Q1 2015 and held it in 25 quarters.
  • Simplex Trading's AbbVie position peaked at $24.6M in Q3 2025.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.